HomeAll ContractsContract
65 VII, INVITRO DIAGNOSTICS, REAGENTS, TEST KITS, & TEST SETS, FSS CONTRACT AWARD
Total Committed
$5.39M
Product or Service Description
In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
Contracting Agency
Effective Date
Jan. 8, 2021
Funding Department
NAC FEDERAL SUPPLY SCHEDULE (36F797)
Type
Fixed price with economic price adjustment
Solicitation Procedure
Subject to multiple award fair opportunity
Extent Competed
Full and open competition

Recent Contract Actions

Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.

Vendor Description Signed Reason for Change Amount Committed
ABBOTT RAPID DX NORTH AMERICA, LLC 65 VII, INVITRO DIAGNOSTICS, REAGENTS, TEST KITS, & TEST SETS, FSS CONTRACT AWARD May 3, 2021 Supplemental Agreement For Work Within Scope -$9,658,123
ABBOTT RAPID DX NORTH AMERICA, LLC RAPID ANTIGEN TESTING FOR COVID Jan. 14, 2021 $50,373
ABBOTT RAPID DX NORTH AMERICA, LLC 65 VII, INVITRO DIAGNOSTICS, REAGENTS, TEST KITS, & TEST SETS, FSS CONTRACT AWARD Jan. 8, 2021 $14,999,948
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.
Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page